The lncRNA cytoskeleton regulator RNA (CYTOR) facilitates epithelial-to-mesenchymal transition (EMT) and metastasis in colon cancer via interacting with β-catenin, which predicts poor prognosis and may be promising therapeutic target of colon cancer (9, 10). Here, CYTOR is linked to malignant colon neoplasm.